Delta-Fly Pharma (TSE:4598) Change In Receivables : 円0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Delta-Fly Pharma Change In Receivables?

Delta-Fly Pharma's change in receivables for the quarter that ended in Dec. 2023 was 円0.00 Mil. It means Delta-Fly Pharma's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

Delta-Fly Pharma's change in receivables for the fiscal year that ended in Mar. 2023 was 円0.00 Mil. It means Delta-Fly Pharma's Accounts Receivable stayed the same from Mar. 2022 to Mar. 2023 .

Delta-Fly Pharma's Accounts Receivable for the quarter that ended in Dec. 2023 was 円0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Delta-Fly Pharma's liquidation value for the three months ended in Dec. 2023 was 円1,636.76 Mil.

Delta-Fly Pharma Change In Receivables Historical Data

The historical data trend for Delta-Fly Pharma's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delta-Fly Pharma Change In Receivables Chart

Delta-Fly Pharma Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Receivables

Get a 7-Day Free Trial

-110.00

110.00

Delta-Fly Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Delta-Fly Pharma Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

Delta-Fly Pharma (TSE:4598) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Delta-Fly Pharma's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Delta-Fly Pharma's accounts receivable are only considered to be worth 75% of book value:

Delta-Fly Pharma's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1727.759	-	91.002	+	0.75 * 0	+	0.5 * 0
=	1,636.76

Delta-Fly Pharma Change In Receivables Related Terms

Thank you for viewing the detailed overview of Delta-Fly Pharma's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Delta-Fly Pharma (TSE:4598) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Delta-Fly Pharma Inc (TSE:4598) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Miyajima Kinno 37-5, Tokushima Prefecture, Kawauchi Town, Tokushima, JPN, 771-0116

Website

http://www.delta-flypharma.co.jp

Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.

Delta-Fly Pharma (TSE:4598) Headlines

No Headlines